(novo nordisk is the patent holder for semaglutide and also sponsored the trials as a whole)
But on the other hand I wasn't thinking clearly, horses are an existing factor that correlate with wealth. This being a pre-market, double blind trial, with a placebo group selected from the same pool of people as those that actually got the semaglutide, that isn't a factor here.
If it was just an observational study across wider populations they'd have to try to control for a lot more factors
https://www.sciencedirect.com/science/article/pii/S0735109724081567
(novo nordisk is the patent holder for semaglutide and also sponsored the trials as a whole)
But on the other hand I wasn't thinking clearly, horses are an existing factor that correlate with wealth. This being a pre-market, double blind trial, with a placebo group selected from the same pool of people as those that actually got the semaglutide, that isn't a factor here.
If it was just an observational study across wider populations they'd have to try to control for a lot more factors